The term French heartworm undoubtedly causes a lot of concern among pet owners and veterinarians. When it comes to the tiny parasite Angiostrongylus vasorum, few people are aware of its mysterious life cycle and the potential harm it poses to dogs. But in fact, the influence of this parasite is far greater than we imagined.
French heartworm is a parasitic nematode that is about 14 to 20 mm long and pink in color. Although the biology of this nematode is not fully understood, the disease it causes in dogs, canine heartworm disease, is a vexing problem. It is worth noting that this parasite is not contagious to humans and is therefore not considered a zoonosis.
The life cycle of French heartworm begins when the third-stage larvae (L3) are ingested by a terminal host such as a dog or fox. This is usually achieved through ingestion of intermediate hosts (such as slugs and clams) or infected food. Once the L3 larvae enter the digestive system, they migrate to the mesenteric lymph nodes and undergo multiple metamorphosis to become adults, which eventually colonize the pulmonary arteries and the right side of the heart.
Adult worms can reportedly live in the heart and pulmonary arteries of their hosts for up to two years, a lengthy reproduction cycle that poses a challenge to detecting and treating the disease.
French heartworm can cause multiple pathological effects on the host, including blood vessel blockage, anemia, and nerve damage. Typical clinical symptoms include chronic cough, exercise intolerance, and dyspnea. These symptoms are all caused by the blockage of blood vessels due to the presence of adults and larvae.
"Neurological damage such as ataxia, epilepsy, and even behavioral changes are all caused by brain hemorrhage."
To confirm the diagnosis, veterinarians usually rely on clinical signs and a variety of tests. Imaging tests can show lung lesions, while blood tests can reveal features such as eosinophilia, poor clotting ability, and anemia.
The main intermediate hosts of French heartworm are mollusks such as slugs and terrestrial snails, and it shows almost no host specificity among different hosts. For the final host, domestic dogs and a variety of carnivorous animals (such as foxes, wolves and other carnivores) may serve as sources of infection.
Currently, infection rates among foxes in south-east England are as high as 23%, making foxes considered an important wild reservoir for the parasite.
The origin of French heartworm is mainly located in Western Europe, including the United Kingdom, Ireland, France and Spain. In recent years, the distribution range of this parasite has continued to expand and has been found in certain areas of North and South America. Its genetic sequence in South America even shows differences from other regions.
Currently approved treatment and prevention in Europe is the use of a drug containing 10% ivermectin (imidacloprid) and 2.5% moxidectin (moxidectin). Dogs infected for the first time usually only require one dose, but a follow-up veterinary visit within 30 days of treatment is recommended to further ensure that the treatment is continuing to work.
It is worth noting that in epidemic areas, it is recommended to use preventive drugs regularly every month, which can effectively prevent the occurrence of infection.
With the spread of French heartworm and the increasing severity of canine heartworm disease, dog lovers should strengthen their awareness of this disease and take preventive measures to further protect our furry friends from threats. In an ever-changing environment, have you begun to consider the impact these tiny parasites may have on your pets?